Karen Ouyang
LabCorp (United States)(US)Invitae (United States)(US)
Publications by Year
Research Areas
Genomics and Rare Diseases, Adolescent and Pediatric Healthcare, Renal cell carcinoma treatment, Pancreatic and Hepatic Oncology Research, BRCA gene mutations in cancer
Most-Cited Works
- → Measuring the predictability of life outcomes with a scientific mass collaboration(2020)316 cited
- → Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing(2023)201 cited
- → Spectrum of splicing variants in disease genes and the ability of RNA analysis to reduce uncertainty in clinical interpretation(2021)87 cited
- → FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney Cancer(2023)71 cited
- → Expanded Gene Panel Use for Women With Breast Cancer: Identification and Intervention Beyond Breast Cancer Risk(2017)67 cited
- → Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing(2021)28 cited
- → Patterns of mosaicism for sequence and copy-number variants discovered through clinical deep sequencing of disease-related genes in one million individuals(2023)25 cited
- → Systematic use of phenotype evidence in clinical genetic testing reduces the frequency of variants of uncertain significance(2022)24 cited
- → Correction: Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria(2019)17 cited
- → Utility of RNA Sequencing Analysis in the Context of Genetic Testing(2020)11 cited